Pre-made Clervonafusp benchmark antibody ( di-Fab Fusion, anti-SLC29A2/ENT2 therapeutic antibody, Anti-DER12/HNP36 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-111

Pre-Made Clervonafusp biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2 Antibody: Anti-DER12/HNP36 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-111-1mg 1mg Inquiry
GMP-Bios-ab-111-10mg 10mg Inquiry
GMP-Bios-ab-111-100mg 100mg Inquiry
GMP-Bios-ab-111-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Clervonafusp biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2 Antibody: Anti-DER12/HNP36 therapeutic antibody
INN Name Clervonafusp
TargetSLC29A2
Formatdi-Fab Fusion
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I/II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
CompaniesValerion Therapeutics
Conditions Approvedna
Conditions ActiveGlycogen storage disease type II
Conditions Discontinuedna
Development Techna